Neonc Technologies Holdings, Inc. (NTHI)
NASDAQ·Healthcare·Biotechnology
$3.41
+6.56%
Mkt Cap $188.76M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$16.50
Range $13.00 – $20.00
Implied Upside
+383.9%
Consensus $16.50 vs current $3.41